侧面是不是很重要? 解读支持结直肠癌侧依赖性病原和治疗反应的解密机制
Harrison J Boka1,2,3, Rebekah M Engel1,2,3, Christine Georges3
1Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, 3800, Australia.
Molecular cancer
|May 1, 2025
概括
与左侧结直肠癌相比,右侧结直肠癌 (CRC) 呈现出侵略性特征和不良结果. 分子差异推动了这些差异,为改进的,特定地点的治疗提供了目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 大肠直肠癌 (CRC) 在瘤位置之间表现出显著的异质性.
- 靠近右侧CRC (RCRC) 与较远左侧CRC (LCRC) 相比,与更具侵略性的特征和较差的患者结局有关.
- 导致RCRC抗治疗的精确分子机制尚不清楚.
研究的目的:
- 审查和对最近分化RCRC和LCRC的分子数据进行上下文化.
- 为了识别RCRC和LCRC之间表达不一致的分子生物标志物.
- 突出未来临床应用和侧向CRC治疗的有前途的候选人.
主要方法:
- 全基因组测序数据的分析.
- 转录概况. 转录概况.
- 单细胞分析. 单细胞分析.
- 关于分子生物标志物不一致性的文献综述.
主要成果:
- 在RCRC和LCRC之间存在关键的分子差异.
- 不同表达的基因涵盖了各种细胞功能.
- 特定的分子生物标志物显示瘤部位之间的不一致.
结论:
- RCRC和LCRC之间的分子差异导致了不同的临床行为.
- 已识别的生物标志物为改善预后评估提供了潜力.
- 这些发现可以为侧向特定CRC疗法的未来研究方向提供信息.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K


